{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:13:27Z","timestamp":1787022807641,"version":"build-2736575974"},"reference-count":30,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":322,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/J003611\/1"],"award-info":[{"award-number":["MR\/J003611\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG11\/4\/28734"],"award-info":[{"award-number":["RG11\/4\/28734"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107049\/Z\/15\/Z"],"award-info":[{"award-number":["107049\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We previously published the DexFEM trial, which showed that in women with heavy menstrual bleeding (HMB), oral dexamethasone reduces menstrual blood loss. Here, we report a pharmacodynamic analysis exploring the likely mechanism for this effect. We studied oral dosing with dexamethasone during the mid-luteal phase of two menstrual cycles (1.5 mg daily, 5 days) in five women with HMB (six recruited aged 41\u201350 years, one withdrew before treatment). Steroid hormones were profiled in serum and endometrium by liquid chromatography-tandem mass spectrometry (LC-MS\/MS). We found that following oral dosing, dexamethasone reached the endometrium and that, compared to the preceding control cycle, cortisol (active), cortisone (inactive) and intermediate 11-deoxycortisol were reduced in all samples assessed, both endometrial (n = 4) and serum (n = 5). Concentrations of androgens, androstenedione and testosterone were reduced in serum but not in all tissue samples. This proof-of-concept pharmacodynamic study supports the inference that dexamethasone is effective in HMB by altering endometrial glucocorticoid concentrations.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance statement<\/jats:title>\n                    <jats:p>New treatments are needed for HMB, a debilitating symptom experienced by many women. The association previously found between local endometrial glucocorticoid deficiency and HMB stimulated research into the role for glucocorticoids in the physiological process of menstruation. We report a proof-of-concept experimental medicine study profiling steroids in endometrial biopsies, demonstrating that dexamethasone administered orally penetrates the endometrium and is associated with changes in circulating endogenous steroid profiles (glucocorticoids and androgens) and in glucocorticoids in the endometrium. Dexamethasone thus has potential utility to modify glucocorticoid profiles and endometrial steroids in those with HMB. These findings augment the results of the recently reported adaptive clinical trial we conducted, also in women with HMB, showing that oral dexamethasone reduces menstrual blood loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-24-0638","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T16:01:40Z","timestamp":1742918500000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":2,"title":["Luteal phase oral dexamethasone administration alters the endometrial steroid milieu"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-2098","authenticated-orcid":true,"given":"Natalie Z M","family":"Homer","sequence":"first","affiliation":[{"name":"Mass Spectrometry Core, Edinburgh Clinical Research Facility, and University\/BHF Centre for Cardiovascular Science, University of Edinburgh, The Queen\u2019s Medical Research Institute 1 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Nicol","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh 2 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Madhra","sequence":"additional","affiliation":[{"name":"Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh 3 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Naredo-Gonzalez","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, The Queen\u2019s Medical Research Institute 4 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Laforest","sequence":"additional","affiliation":[{"name":"Mass Spectrometry Core, Edinburgh Clinical Research Facility, and University\/BHF Centre for Cardiovascular Science, University of Edinburgh, The Queen\u2019s Medical Research Institute 1 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ov D","family":"Slayden","sequence":"additional","affiliation":[{"name":"Oregon National Primate Research Center 5 , , ,","place":["Beaverton, Oregon, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Hillier","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh 2 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Walker","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle, UK 6"},{"name":"7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Warner","sequence":"additional","affiliation":[{"name":"Usher Institute of Population Health Sciences & Informatics, University of Edinburgh 8 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Andrew","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, The Queen\u2019s Medical Research Institute 4 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-4044","authenticated-orcid":true,"given":"Hilary O D","family":"Critchley","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh 2 , ,","place":["Edinburgh, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"2026070710583902800_bib1","volume-title":"National heavy menstrual bleeding audit \u2013 final report","author":"Royal College of Obstetricians and Gynaecologists","year":"2014"},{"key":"2026070710583902800_bib2","volume-title":"NG88: Heavy menstrual bleeding: assessment and management","author":"National Institute for Health and Care Excellence"},{"key":"2026070710583902800_bib3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1152\/physrev.00031.2019","article-title":"Physiology of the endometrium and regulation of menstruation","volume":"100","author":"Critchley","year":"2020","journal-title":"Physiol Rev"},{"key":"2026070710583902800_bib4","first-page":"240","article-title":"Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy","volume":"84","author":"Critchley","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710583902800_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1365-2265.2001.01432.x","article-title":"The endocrinology of menstruation--a role for the immune system","volume":"55","author":"Critchley","year":"2001","journal-title":"Clin Endocrinol"},{"key":"2026070710583902800_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/jc.2002-021174","article-title":"Steroid receptor expression in uterine natural killer cells","volume":"88","author":"Henderson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710583902800_bib7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2008-1879","article-title":"Cortisol inactivation by 11\u03b2-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation","volume":"94","author":"Rae","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710583902800_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1196\/annals.1366.030","article-title":"Local amplification of glucocorticoids by 11\u03b2-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response","volume":"1088","author":"Chapman","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2026070710583902800_bib9","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1161\/hc4801.100077","article-title":"Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11\u03b2-hydroxysteroid dehydrogenase","volume":"104","author":"Hadoke","year":"2001","journal-title":"Circulation"},{"key":"2026070710583902800_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.1.06019","article-title":"11\u03b2-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action","volume":"186","author":"Draper","year":"2005","journal-title":"J Endocrinol"},{"key":"2026070710583902800_bib11","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/humrep\/del503","article-title":"Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation","volume":"22","author":"Smith","year":"2007","journal-title":"Hum Reprod"},{"key":"2026070710583902800_bib12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI37398","article-title":"Inhibition of 11\u03b2\u2013hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans","volume":"119","author":"Zhang","year":"2009","journal-title":"J Clin Investig"},{"key":"2026070710583902800_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1471-0528.1981.tb01009.x","article-title":"Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding","volume":"88","author":"Smith","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"2026070710583902800_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0090-6980(83)90122-3","article-title":"Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?","volume":"25","author":"Lumsden","year":"1983","journal-title":"Prostaglandins"},{"key":"2026070710583902800_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0301-2115(96)02568-7","article-title":"Prostaglandins and menstruation","volume":"70","author":"Baird","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026070710583902800_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103434","article-title":"Low dose dexamethasone as treatment for women with heavy menstrual bleeding: a response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM)","volume":"69","author":"Warner","year":"2021","journal-title":"EBioMedicine"},{"key":"2026070710583902800_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006837","article-title":"Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM)","volume":"5","author":"Warner","year":"2015","journal-title":"BMJ Open"},{"key":"2026070710583902800_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2024.102728","article-title":"A practical approach to supported liquid extraction and measurement of 18 steroids in plasma and serum by targeted liquid chromatography tandem mass spectrometry","volume":"12","author":"Denham","year":"2024","journal-title":"MethodsX"},{"key":"2026070710583902800_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105476","article-title":"Simultaneous quantification of estrogens and glucocorticoids in human adipose tissue by liquid-chromatography-tandem mass spectrometry","volume":"195","author":"Laforest","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070710583902800_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijgo.14946","article-title":"Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO systems 1 and 2","volume":"162","author":"Jain","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"2026070710583902800_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/cen.13548","article-title":"Pulsatility of glucocorticoid hormones in pregnancy: changes with gestation and obesity","volume":"88","author":"Stirrat","year":"2018","journal-title":"Clin Endocrinol"},{"key":"2026070710583902800_bib22","first-page":"457","article-title":"The serum transport of steroid hormones","volume":"38","author":"Siiteri","year":"1982","journal-title":"Recent Prog Horm Res"},{"key":"2026070710583902800_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mce.2005.12.010","article-title":"11\u03b2-Hydroxysteroid dehydrogenases in human endometrium","volume":"248","author":"McDonald","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2026070710583902800_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpba.2018.01.034","article-title":"Analysis by LC-MS\/MS of endogenous steroids from human serum, plasma, endometrium and endometriotic tissue","volume":"152","author":"H\u00e4kkinen","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"2026070710583902800_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpba.2018.11.035","article-title":"Simultaneous analysis by LC-MS\/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue","volume":"164","author":"Hakkinen","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"2026070710583902800_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/joe.0.1530041","article-title":"Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo","volume":"153","author":"Best","year":"1997","journal-title":"J Endocrinol"},{"key":"2026070710583902800_bib27","article-title":"Estrogen receptor function: impact on the human endometrium","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026070710583902800_bib28","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JOE-20-0106","article-title":"Androgens, oestrogens and endometrium: a fine balance between perfection and pathology","volume":"246","author":"Gibson","year":"2020","journal-title":"J Endocrinol"},{"key":"2026070710583902800_bib29","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/jc.2013-3375","article-title":"Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism","volume":"98","author":"Handelsman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710583902800_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ijgo.14331","article-title":"The FIGO ovulatory disorders classification system","volume":"159","author":"Munro","year":"2022","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/5\/EC-24-0638.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/5\/EC-24-0638.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0638\/9468\/ec-24-0638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0638\/9468\/ec-24-0638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:24:05Z","timestamp":1783437845000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/5\/e240638\/1390\/Luteal-phase-oral-dexamethasone-administration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0638","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"e240638"}}